Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Alprostadil is the active ingredient of these drugs:
Ecuador
Austria
Turkey
Austria Ecuador
Turkey
Australia Austria Brazil Canada Cyprus
France Tunisia United States
Turkey
Japan
Austria
Austria Canada Estonia Finland Ireland
Japan
Austria Romania
Austria Brazil Poland Turkey
Canada Estonia Hong Kong Netherlands New Zealand
France
Estonia Finland
Lithuania Romania
Estonia
Estonia United Kingdom
Spain
Austria Cyprus Finland France Ireland
Poland